(Q27851852)
Statements
1 reference
Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial (English)
1 reference
August 2012
0 references
13
0 references
8
0 references
773-81
0 references